Status:

COMPLETED

Levocarnitine in Treating Fatigue in Cancer Patients

Lead Sponsor:

ECOG-ACRIN Cancer Research Group

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Fatigue

Unspecified Adult Solid Tumor, Protocol Specific

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

RATIONALE: Levocarnitine may help improve energy levels in cancer patients. PURPOSE: This randomized phase III trial is studying how well levocarnitine works compared to a placebo in treating fatigue...

Detailed Description

OBJECTIVES: Primary Objective: * Compare the efficacy of levocarnitine (L-carnitine) supplementation vs placebo for the management of fatigue in patients with cancer. Secondary Objectives: * Asses...

Eligibility Criteria

Inclusion

  • Diagnosis of an invasive malignant disorder
  • Moderate to severe fatigue within the past 4 weeks, defined as a score of ≥ 2 (on a scale of 0-4) on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) question "I feel fatigued"
  • Age 18 and over
  • Eastern Cooperative Oncology Group (ECOG) Performance status of 0-3
  • Negative pregnancy test
  • Fertile patients must use effective contraception during and for 3 months after study participation

Exclusion

  • Brain metastases
  • Hemoglobin \< 9 g/dL, taken \<=4 weeks prior to registration
  • Severe, uncontrolled liver disease
  • Evidence of severely compromised renal function including any 1 of the following:
  • Renal failure
  • End stage renal disease
  • Ongoing renal dialysis
  • Severe, uncontrolled cardiovascular disease
  • Severe, uncontrolled pulmonary disease
  • Pregnant or nursing
  • History of seizures
  • Known sensitivity to carnitine
  • Delirium
  • Nausea \> grade 1
  • Taking any form of levocarnitine (L-carnitine) supplementation or nutritional supplements containing carnitine within 2 months prior to registration

Key Trial Info

Start Date :

December 16 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2011

Estimated Enrollment :

376 Patients enrolled

Trial Details

Trial ID

NCT00091169

Start Date

December 16 2005

End Date

May 1 2011

Last Update

July 5 2023

Active Locations (116)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 29 (116 locations)

1

Veterans Affairs Medical Center - Palo Alto

Palo Alto, California, United States, 94304

2

Stanford Comprehensive Cancer Center - Stanford

Stanford, California, United States, 94305

3

Praxair Cancer Center at Danbury Hospital

Danbury, Connecticut, United States, 06810

4

Manchester Memorial Hospital

Manchester, Connecticut, United States, 06040

Levocarnitine in Treating Fatigue in Cancer Patients | DecenTrialz